Sign up for free insights newsletter
60

Dashenlin Pharm Grp Co Ltd

603233SHG

Need professional-grade analysis? Visit stockanalysis.com

CN¥17.27
-4.64%
End of day
Market Cap

$21.38B

P/E Ratio

18.58

Employees

43,532

Dividend Yield

3.44%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino0.030.470.28
Calmar0.040.500.30
Sharpe0.020.320.19
Omega1.031.081.06
Martin0.101.140.68
Ulcer6.938.277.68

Dashenlin Pharm Grp Co Ltd (603233) Price Performance

Dashenlin Pharm Grp Co Ltd (603233) trades on SHG in CNY. The company is classified in the Healthcare sector under the Pharmaceutical Retailers industry. The stock currently trades at CNY17.27, down 4.64% from the previous close.

Over the past year, 603233 has traded between a low of CNY15.58 and a high of CNY21.27. The stock has gained 7.1% over this period. It is currently 18.8% below its 52-week high.

Dashenlin Pharm Grp Co Ltd has a market capitalization of $21.38B, with a price-to-earnings ratio of 18.58 and a dividend yield of 3.44%.

About Dashenlin Pharm Grp Co Ltd

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, distributes, and retails pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and antler tonic medicinal materials, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.

Company Info

Exchange
SHG
Currency
CNY
Country
China

Financial Metrics

Revenue (TTM)
$26.83B
EBITDA
$3.54B
Profit Margin
4.24%
EPS (TTM)
1.01
Book Value
6.35

Technical Indicators

52 Week High
CN¥21.78
52 Week Low
CN¥15.08
50 Day MA
CN¥19.40
200 Day MA
CN¥17.88
Beta
0.64

Valuation

Trailing P/E
18.58
Forward P/E
N/A
Price/Sales
0.80
Price/Book
2.98
Enterprise Value
$20.85B